Might be lagging a little bit. In the past PTX seems to have gained some traction before most other biotechs but we haven't really had much price action. Except for the little peak in early June - maybe that was all we were going to get....
Time will tell if the team can execute, but I think the partnerships that have been forged will help this tech be noticed by commercialisation experts. IMO PTX is missing that capability internally which is holding it back slightly. And look, they might not be at that stage yet, they're still undertaking trials and appear to have some great tech. Their timeline needs to be articulated a lot easier than what it currently is... I know they're gunning for a buy-out by big pharma but they haven't really highlighted the steps they're taking to get there, they're just doing a bunch of trials and hoping that attracts big pharma - but what if it doesn't?
PTX is still very undervalued, once we get some partnerships with key institutional investors we should see some traction and hopefully it pushes the price up where traders can't profit much on the pips.
PTX Price at posting:
5.9¢ Sentiment: Buy Disclosure: Held
